MedTrace Logo

ATTR Cardiac Amyloidosis in a Selected Population

NCT06458374 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2024-10-16

No results posted yet for this study

Summary

Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.

Conditions

  • ATTR Amyloidosis Wild Type
  • ATTR Gene Mutation
  • Carpal Tunnel Syndrome
  • Cardiac Amyloidosis

Sponsors & Collaborators

  • Helse Møre og Romsdal HF

    lead OTHER_GOV

Principal Investigators

  • Torstein Hole, MD, PhD · Helse Møre og Romsdal HF and NTNU

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2034-02-28
Completion
2039-02-28

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06458374 on ClinicalTrials.gov